The World Egg and Sperm Bank faces scrutiny over a proposed “Client Success Reward Program” that would reward Australian IVF clinics with credits toward donor egg cohorts.
An email obtained by the ABC shows TWESB telling clinics that credits could offset, or even fully cover, the cost of donor eggs for patients. The credits would be applied to the clinic’s TWESB account, purportedly giving clinics flexibility to support patients in need.
TWESB, headquartered in Arizona with a defined presence in Australia, has not implemented the program. A company statement said they only outlined a potential clinic-based support model to improve patient access to treatment with donor gametes, but it was not put into practice. TWESB emphasized its commitment to transparency, ethics, and regulatory compliance across all markets where it operates.
The proposal has drawn cautious responses from Australian fertility authorities. The Fertility Society of Australia and New Zealand (FSANZ) acknowledged awareness of the points-based plan and advised members to proceed with caution.
FSANZ noted that Australia already faces a donor shortage and warned that overseas partnerships can bring legal, ethical, and logistical challenges. The organization called for national harmonization of laws governing assisted reproductive technology, including IVF, and a national donor register to ensure transparency and protection for donors and families.
Industry voices warn that such reward schemes could carry reputational and ethical risks. Brisbane-based IVF physician David Molloy, chair of the IVF Medical Directors’ Group Australia within FSANZ, has urged clinics to seek ethical and legal advice before participating in inducement schemes. He warned about potential reputational damage and stressed the need to keep donor sperm and eggs management to the highest standards.
Some experts acknowledge potential benefits if a rewards program lowered costs for patients. Dr Molly Johnston, an ARC Industry Fellow at Monash University’s Bioethics Centre, suggested that savings could improve access to IVF for families.
Yet she cautioned that loyalty programs could create financial incentives for clinics to favor gametes from a particular bank, risking conflicts of interest and compromising patient autonomy. She warned that such schemes could influence clinical decision-making and potentially undermine the moral significance of procreation.
TWESB has faced renewed attention in a year marked by scrutiny of Australia’s fertility sector. Earlier this year, two embryo mix-ups at Monash IVF prompted health ministers to initiate a rapid industry review. The current conversation around donor gametes, ethics, and patient access continues to shape policy discussions in Australian reproductive medicine.
Related topics
